+ Watch CMXI
on My Watchlist
A biotechnology company that develops and licenses autologous cellular therapies, including Cytomedix's proprietary AutoloGel(tm) Process to produce a platelet rich plasma gel for the treatment of wounds.
Seems interesting. spec play
CMXI has made me a lot of money with a timely investment. With their recent agreement with a global pharmaceutical company after their October 15 medical symposium in Las Vegas, they recieved a $2 million option fee, I expect their upcoming 3rd quarter earnings statement to be much higher than expected. 3rd quarter earnings are released by CMXI on November 11 so look to this date to see another aggressive growth in this stock price. I feel like this company is about to make a charge. I also recently read that company executives just bought the maximum allowed shares.....maybe they know something good is about to happen in November? I know I will definitely be on board as this company is poised to pop as it expands in globalization and starts being used in the United States.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions